Abstract
Nonspecific orbital inflammation (NSOI) is a term used to describe nonmalignant inflammation of the orbit characterized by a polymorphous lymphoid infiltrate with varying degrees of fibrosis, without a known local or systemic cause. The emphasis is on lack of finding a known cause. Orbital inflammation itself is not a diagnosis, but rather a description of a tissue response to some underlying problem, such as infection, irritation, or injury, which has triggered the immune system. The injured cells release chemical factors stimulating the inflammatory response which is characterized by symptoms of pain, redness, swelling, warmth, and possible dysfunction of the tissues involved. In the case of the orbit, it is infiltration of orbital soft tissues by chronic inflammatory cells that causes findings such as proptosis, eyelid swelling, chemosis, pain, diplopia, or visual loss. Every effort must first be made to identify a specific cause of the inflammation. Navigating through the differential diagnosis of diseases that can cause or simulate orbital inflammation is challenging; however, adhering to a methodical history and exam will help facilitate the process. Only once all other specific etiologies have been eliminated can one conclude with the diagnosis of nonspecific orbital inflammation, which only means that the causative pathogen or trigger could not be identified.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kennerdell JS, Dresner SC. The nonspecific orbital inflammatory syndromes. Surv Ophthalmol. 1984;29(2):93–103.
Birch-Hirschfeld A. Handbuch der Gesamten Augenheilkunde. Berlin: Julius Springer; 1930. p. 251.
Rootman J. Why “orbital pseudotumour” is no longer a useful concept. Br J Ophthalmol. 1998;82(4):339–40.
Wladis EJ, Iglesias BV, Gosselin EJ. Characterization of the molecular biologic milieu of idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 2011;27(4):251–4.
Wladis EJ, Iglesias BV, Adam AP, Nazeer T, Gosselin EJ. Toll-like receptors in idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 2012;28(4):273–6.
Cockerham KP, Hong SH, Browne EE. Orbital inflammation. Curr Neurol Neurosci Rep. 2003;3(5):401–9.
Mombaerts I, et al. What is orbital pseudotumor? Surv Ophthalmol. 1996;41(1):66–78.
Bloom JN, Graviss ER, Byrne BJ. Orbital pseudotumor in the differential diagnosis of pediatric uveitis. J Pediatr Ophthalmol Strabismus. 1992;29(1):59–63.
Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol. 2012;96(2):276–80.
McCarthy JM, et al. Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis. Mod Pathol. 1993;6(5):581–7.
Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. Faseb J. 1994;8(11):854–61.
Raskin EM, et al. Granulomatous idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 1995;11(2):131–5.
Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol. 2013;91(8):694–700.
Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease? Am J Surg Pathol. 2007;31(4):643–5.
Stone JH M.D., M.P.H., Yoh Zen M.D., Ph.D., Deshpande V M.D. IgG4-related disease. N Engl J Med. 2012;366:539–51.
Uehara F, Ohba N. Diagnostic imaging in patients with orbital cellulitis and inflammatory pseudotumor. Int Ophthalmol Clin. 2002;42(1):133–42.
Kapur R, Sepahdari AR, Mafee MF, Putterman AM, Aakalu V, Wendel LJ, Setabutr P. MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol. 2009;30(1):64–70.
Patrinely JR, et al. Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology. 1989;96(7):1038–47.
Ben Simon GJ, Syed HM, Douglas R, McCann JD, Goldberg RA. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. Am J Ophthalmol. 2004;137(6):1145–7.
Papalkar D, et al. A rapidly fatal case of T-cell lymphoma presenting as idiopathic orbital inflammation. Orbit. 2005;24(2):131–3.
Rootman J, editor. Orbital disease: present status and future challenge. Boca Raton: Taylor & Francis Group, LLC; 2005. p. 1–13.
Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491–9.
Mombaerts I, et al. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103(3):521–8.
Garrity JA, Coleman AW, Matteson EL, et al. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138:925–30.
Miguel T, Abad S, Badelon I, Vignal C, et al. Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents. Ophthal Plast Reconstr Surg. 2008;24(5):415–7.
Lanciano R, Fowble B, Sergott RC, Atlas S, Savino PJ, Bosley TM, Rubenstein J. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18(2):407–11.
Maalouf T, et al. What has become of our idiopathic inflammatory pseudo-tumors of the orbit? Orbit. 1999;18(3):157–66.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gausas, R.E., Damani, M.R., Cockerham, K.P. (2014). Nonspecific Orbital Inflammation. In: Perry, J., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40492-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-40492-4_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40491-7
Online ISBN: 978-3-642-40492-4
eBook Packages: MedicineMedicine (R0)